Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01371890 · ClinicalTrials.gov registry record
Mechanisms and Treatment of Intradialytic Hypertension - Sodium
A clinical trial, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- 18
- Enrollment target
NCT01371890 is a clinical trial that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 18 participants.
The verdict
NCT01371890 has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- 18 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the role of dialysate exposure and fluid removal during hemodialysis in the pathophysiology of intradialytic hypertension.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2011-05 |
| Est. Completion | 2012-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01371890
The ClinicalTrials.gov registry entry for NCT01371890 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01371890 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01371890 about?
NCT01371890 is a clinical study titled "Mechanisms and Treatment of Intradialytic Hypertension - Sodium". The purpose of this study is to determine the role of dialysate exposure and fluid removal during hemodialysis in the pathophysiology of intradialytic hypertension.
What is the current status of trial NCT01371890?
This trial is currently completed. The enrollment target is 18 participants. The study started on 2011-05. Estimated completion is 2012-08.
Who is sponsoring clinical trial NCT01371890?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.